04:57 AM EST, 02/24/2025 (MT Newswires) -- Chad M Robins, Director, Chief Executive Officer and Chairman, on February 19, 2025, sold 285,187 shares in Adaptive Biotechnologies ( ADPT ) for $2,410,700. Following the Form 4 filing with the SEC, Robins has control over a total of 2,576,701 shares of the company, with 2,576,701 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1478320/000106299325003241/xslF345X05/form4.xml